<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_YZA6xSk">Association of the erythropoiesis-stimulating agent resistance index and the geriatric nutritional risk index with cardiovascular mortality in maintenance hemodialysis patients</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">© 2021 Yajima et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
				</availability>
				<date type="published" when="2021-01-15">January 15, 2021</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Takahiro</forename><surname>Yajima</surname></persName>
							<email>yajima5639@gmail.com</email>
							<idno type="ORCID">0000-0002-8180-5614</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Nephrology , Matsunami General Hospital , Gifu , Japan ,</note>
								<orgName type="department">Department of Nephrology</orgName>
								<orgName type="institution">Matsunami General Hospital</orgName>
								<address>
									<settlement>Gifu</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kumiko</forename><surname>Yajima</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Internal Medicine , Matsunami General Hospital , Gifu , Japan ,</note>
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">Matsunami General Hospital</orgName>
								<address>
									<settlement>Gifu</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hiroshi</forename><surname>Takahashi</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Division of Medical Statistics , Fujita Health University School of Medicine , Aichi , Japan</note>
								<orgName type="department">Division of Medical Statistics</orgName>
								<orgName type="institution">Fujita Health University School of Medicine</orgName>
								<address>
									<settlement>Aichi</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation">University of Florida , UNITED STATES</note>
								<orgName type="institution">University of Florida</orgName>
								<address>
									<country key="US">UNITED STATES</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_xvWkXVG">Association of the erythropoiesis-stimulating agent resistance index and the geriatric nutritional risk index with cardiovascular mortality in maintenance hemodialysis patients</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2021-01-15">January 15, 2021</date>
						</imprint>
					</monogr>
					<idno type="MD5">1FC58E7EB606023FBD844BCA20D9CC80</idno>
					<idno type="DOI">10.1371/journal.pone.0245625</idno>
					<note type="submission">Received: October 23, 2020 Accepted: January 4, 2021</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T12:07+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_xZfsUTk">Objective</head><p xml:id="_dBWd3ph"><s xml:id="_varPphx">Hyporesponsiveness to erythropoiesis-stimulating agent (ESA) may be associated with protein-energy wasting.</s><s xml:id="_rmRvQ4B">We investigated the relationship of the ESA resistance index (ERI) and the geriatric nutritional risk index (GNRI) for cardiovascular mortality in hemodialysis (HD) patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_B6VXsdQ">Methods</head><p xml:id="_s8fVVEd"><s xml:id="_haxjb6Y">A total of 180 maintenance HD patients were enrolled.</s><s xml:id="_F5PY6gJ">The patients were stratified by the GNRI of 91.2, a previously reported cut-off value, and the ERI of 13.7 (IU/week/kg/g/dL), a cut-off value for predicting cardiovascular-specific mortality, and they were classified into four groups (group 1[G1]: higher GNRI and lower ERI, G2: higher GNRI and higher ERI, G3: lower GNRI and lower ERI, G4: lower GNRI and higher ERI).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_EHpVUKS">Results</head><p xml:id="_pS7QdCZ"><s xml:id="_VXKDV2W">The ERI was independently associated with the GNRI (β = -0.271,</s><s xml:id="_R7reuE6">p = 0.0005).</s><s xml:id="_Dnv6eCk">During a median follow-up of 4.6 years, higher ERI and lower GNRI were independently associated with cardiovascular mortality, respectively (adjusted hazard ratio [aHR], 3.10; 95% confidence interval [CI], and aHR, 6.64; 95%CI, respectively).</s><s xml:id="_xS4JnuJ">The 7year survival rates were 96.1%, 70.3%, 77.3%, and 50.1% in G1, G2, G3, and G4, respectively.</s><s xml:id="_6YhxDHz">The aHR values for G4 versus G1 were 12.63 (95%CI,.</s><s xml:id="_RdsSJSm">With regards to model discrimination, adding the GNRI alone, the ERI alone, and both to the traditional risk model significantly improved the net reclassification improvement by 0.421, 0.662, and 0.671, respectively.</s><s xml:id="_2hypkAY">Similar results were obtained for all-cause mortality.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_7AkET3H">Introduction</head><p xml:id="_Kq5TDsp"><s xml:id="_w4sj5uT">Renal anemia, which is caused by decreased erythropoietin production due to kidney injury, is common among patients undergoing hemodialysis (HD), and is treated with erythropoiesisstimulating agents (ESAs).</s><s xml:id="_ha5dhBD">It has been shown that HD patients who receive a high dose of ESAs relative to the hemoglobin (Hb) response experience poor outcomes, including increased risk of cardiovascular events or mortality <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref>.</s><s xml:id="_pMGZS6g">It is not yet known whether these risks are caused by ESAs themselves, or underlying processes leading to increased ESA requirements.</s><s xml:id="_WDbnbsN">ESA hyporesponsiveness, or resistance, is generally defined as the requirement of higher than average doses of ESA to achieve an increase in Hb concentration <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref>.</s><s xml:id="_T3nmkGj">The ESA resistance index (ERI) has been proposed as an indicator for ESA hyporesponsiveness, and some previous studies have shown that the ERI can predict all-cause mortality and/or cardiovascular events <ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref>.</s><s xml:id="_ht4EUxZ">However, the associations between the ERI and cardiovascular mortality remain unclear.</s></p><p xml:id="_npED6yP"><s xml:id="_m3eHaj9">The mechanisms of ESA hyporesponsiveness are not fully understood, but are likely to be multifactorial, relating to iron deficiency, inflammation, and malnutrition <ref type="bibr" target="#b8">[9]</ref>.</s><s xml:id="_KHfWDYT">Recently, some studies have speculated that ESA hyporesponsiveness may be related to protein-energy wasting (PEW), a form of malnutrition characterized by loss of body protein and fuel reserves due to catabolic inflammation <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b10">11]</ref>.</s><s xml:id="_67xShRq"><ref type="bibr">Okazaki et al.</ref> recently reported that high ERI and low geriatric nutritional risk index (GNRI) were associated with an increased risk of all-cause mortality in HD patients <ref type="bibr" target="#b11">[12]</ref>.</s><s xml:id="_SBw55TA">The GNRI can be used to classify patients according to a risk of complications in relation to conditions associated with PEW <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14]</ref>, and is also known to be an effective tool to identify those with malnutrition-related risks of all-cause and cardiovascular mortality in this population <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref>.</s></p><p xml:id="_ncX8vGY"><s xml:id="_BqyrCFW">We investigated the associations of the ERI and the GNRI with cardiovascular and all-cause mortality in maintenance HD patients.</s><s xml:id="_xREu4KP">In addition, we evaluated the combined predictability of the ERI and the GNRI for mortality in this population.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_MFAeQuU">Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_THpc8jn">Study participants</head><p xml:id="_fwH6qu5"><s xml:id="_wcQGED2">We conducted a retrospective cohort study of patients who had undergone maintenance hemodialysis therapy for at least 6 months.</s><s xml:id="_z6YPkyU">Patients who were treated with epoetin beta or darbepoetin alfa, but not with epoetin beta pegol for renal anemia were included.</s><s xml:id="_QWpraC5">The study was performed using the medical records of the outpatient clinic of Matsunami General Hospital (Kasamatsu, Japan) between January 2008 and March 2020.</s><s xml:id="_tHYS92v">Patients' data were fully anonymized prior to access, and as such, the requirement for informed consent was waived.</s><s xml:id="_XasPQUa">This study adhered to the principles of the Declaration of Helsinki, and the study protocol was approved by the Ethics Committee of Matsunami General Hospital (No. 459).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_yPpDEAF">Data collection</head><p xml:id="_bYCAd5F"><s xml:id="_QXJ529t">The following patient data were collected from medical records: Age; sex; underlying kidney disease; duration of hemodialysis; history of alcohol, smoking, diabetes, hypertension, and cardiovascular disease (CVD); dry weight; and height.</s><s xml:id="_ED2wESx">CVD was defined as heart failure, angina pectoris, myocardial infarction, stroke, and peripheral artery disease.</s><s xml:id="_qjf3mPv">Diabetes was defined as a history or presence of diabetes, or prescription of glucose-lowering agents.</s><s xml:id="_Bmx7c4V">Hypertension was defined as systolic blood pressure � 140 mmHg and/or diastolic blood pressure � 90 mmHg before hemodialysis, and/or prescription of anti-hypertensive drugs.</s><s xml:id="_pZx8vTf">Blood samples were collected in the supine position before hemodialysis sessions, which were conducted on either a Monday or a Tuesday.</s><s xml:id="_Jqs3tBq">For the assessment of ESA responsiveness, the ERI was calculated by dividing the weekly weight-adjusted ESA dose (IU/week/kg) by the Hb concentration (g/dL) <ref type="bibr" target="#b5">[6]</ref>.</s><s xml:id="_Fr7TJMQ">The darbepoetin alfa dose was harmonized with erythropoietin data by multiplying by 200 <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b18">19]</ref>.</s><s xml:id="_86myQzu">The GNRI was calculated as follows: GNRI = (14.89</s><s xml:id="_MsVJDvU">× albumin g/dL) + [41.7× (dry weight/ideal body weight)] <ref type="bibr" target="#b12">[13]</ref>.</s><s xml:id="_ErCjfcR">When the dry weight exceeded the ideal body weight, the "(dry weight/ideal body weight)" element was set to 1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KZyTXHE">Follow-up study</head><p xml:id="_XgfQDmR"><s xml:id="_nQ57JCC">The primary endpoint was CVD mortality, and the secondary endpoint was all-cause mortality.</s><s xml:id="_p8KHkNn">Patients were divided by each cut-off point of ERI and GNRI; thereafter, patients were divided into four groups based on the combinations of each cut-off point of ERI and GNRI: Group 1 (G1), higher GNRI and lower ERI; G2, higher GNRI and higher ERI; G3, lower GNRI and lower ERI; and G4, lower GNRI and higher ERI.</s><s xml:id="_cPXHKWv">The patients were followed up until March 2020.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ha5v9tW">Statistical analysis</head><p xml:id="_mzuBYyA"><s xml:id="_uJWak2W">Normally distributed variables are expressed as means ± standard deviations, and non-normally distributed variables are expressed as medians and interquartile ranges.</s><s xml:id="_KeR2V7T">The differences among the four subgroups divided by the GNRI and the ERI were compared by one-way analysis of variance or the Kruskal-Wallis test for continuous variables, or by the chi-squared test for categorical variables.</s><s xml:id="_qc3ZjWK">Univariate regression analysis was performed to determine factors correlated with the ERI.</s><s xml:id="_mhAaFsw">Multivariate regression analysis was performed with the factors that were significantly associated with the ERI in the univariate analysis.</s></p><p xml:id="_PXxgV7s"><s xml:id="_EfZZ9va">A cut-off value of GNRI 91.2 was used; this value was defined from a previous study <ref type="bibr" target="#b12">[13]</ref>.</s><s xml:id="_xnybcqK">Receiver operating characteristic (ROC) analysis was used to determine a cut-off value of the ERI to maximize the predictive value for cardiovascular-specific mortality.</s><s xml:id="_CcaZkHm">The Kaplan-Meier method was used to estimate the survival rate, and the difference was analyzed using the logrank test.</s><s xml:id="_rtf99yQ">Hazard ratios (HRs) and 95% confidence intervals (CIs) for cardiovascular and allcause mortality were calculated by Cox proportional hazard regression analysis.</s><s xml:id="_79AKwEx">The multiple regression model included all covariates that were significant at p &lt; 0.05 in the univariate analysis.</s></p><p xml:id="_5pZgXfk"><s xml:id="_2a7k6n3">The C-index, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were calculated in order to assess whether the accuracy of predicting mortality improved after adding the GNRI and/or the ERI to the baseline model.</s><s xml:id="_CT6VrUj">The C-index was defined as the area under the receiver operating characteristic curve between individual predictive probabilities for mortality and the incidence of mortality.</s><s xml:id="_YPTE3h8">The C-index was compared between the baseline model, with all established risk factors, and the enriched model, including the GNRI and/or the ERI <ref type="bibr" target="#b19">[20]</ref>.</s><s xml:id="_rhtQmSk">The NRI was used as a relative indicator of the number of patients for whom the predicted mortality risk improved, and the IDI was used to show the average improvement in predicted mortality risk after adding the new variables to the baseline model <ref type="bibr" target="#b20">[21]</ref>.</s><s xml:id="_WDUJ6tZ">All statistical analyses were performed using IBM SPSS Version 21 (IBM Corp., Armonk, NY, USA).</s><s xml:id="_fEtvED4">A p-value &lt; 0.05 was considered statistically significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_aU2tcXV">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NHJVU7u">Baseline characteristics</head><p xml:id="_9mpVN68"><s xml:id="_wFtgFPA">The baseline characteristics of the included patients are shown in Table <ref type="table">1</ref>.</s><s xml:id="_9TbBw8G">A total of 180 HD patients were included (age, 63.4 ± 13.9 years; male, 68.3%; HD duration, 0.6 [0.5-4.5]</s><s xml:id="_utWT7Hm">years; history of CVD, 67.8%).</s><s xml:id="_HZdVtjT">Hemoglobin, ferritin, transferrin saturation (TSAT), ESA dose, ERI, and GNRI levels were 10.7 ± 1.3 g/dL, 110 (49-201) ng/mL, 26.1 ± 12.7%, 4500 (4000-9000) IU/week, 8.7 (5.2-14.9)</s><s xml:id="_cnzfkG6">IU/week/kg/g/dL, and 94.5 ± 6.9, respectively.</s><s xml:id="_uR2MaUX">Univariate regression analysis showed that the ERI was significantly correlated with age (β = 0.254, p = 0.0006),</s></p><p xml:id="_Cv5a66A"><s xml:id="_czqgssv">Table 1.</s><s xml:id="_u46mtM7">Baseline characteristics of the study patients.</s><s xml:id="_zcEDt2f">All patients (n = 180) G1 (n = 93) G2 (n = 20) G3 (n = 32) G4 (n = 35) p-value Age (years) 63.4 ± 13.9 59.0 ± 13.6 67.2 ± 10.3 64.7 ± 16.3 71.5 ± 9.3 &lt; 0.0001 Male (%) 68.3 68.8 75.0 68.8 62.9 0.82 Underlying kidney disease 0.92 Diabetic kidney disease (%) 45.0 48.4 45.0 37.5 42.9 Chronic glomerulonephritis (%) 32.2 32.3 25.0 37.5 31.4</s><s xml:id="_rw2JtrR">Nephrosclerosis (%) 17.8 16.1 25.0 15.6 20.0 Others (%) 5.0 3.2 5.0 9.4 5.7 HD duration (years) 0.6 (0.5-4.5) 1.0 (0.5-4.7) 0.6 (0.5-3.8) 0.5 (0.5-4.8) 0.5 (0.5-3.9) 0.55 Alcohol (%) 26.7 28.0 25.0 25.0 25.7 0.98 Smoking (%) 30.0 32.2 30.0 28.1 25.7 0.90 Hypertension (%) 95.6 96.8 100 90.6 94.3 0.30 Diabetes (%) 46.7 48.4 55.0 40.6 42.9 0.72 History of CVD (%) 67.8 66.7 60.0 65.6 77.1 0.54 Dw (kg) 57.7 ± 11.9 62.8 ± 11.9 52.2 ± 8.4 54.7 ± 8.2 50.2 ± 10.3 &lt; 0.0001 BMI (kg/m 2 ) 22.2 ± 3.6 23.8 ± 3.5 19.4 ± 2.9 22.0 ± 2.7 19.9 ± 2.9 &lt; 0.0001 BUN (mg/dL) 61.4 ± 16.7 64.9 ± 16.4 59.2 ± 13.2 58.0 ± 20.6 56.3 ± 14.0 0.028 Creatinine (mg/dL) 9.2 ± 3.2 9.8 ± 3.6 8.4 ± 2.2 9.0 ± 2.7 8.3 ± 2.1 0.050 Single-pool Kt/V for urea 1.3 ± 0.3 1.3 ± 0.3 1.4 ± 0.3 1.4 ± 0.3 1.4 ± 0.4 0.19 Albumin (g/dL) 3.7 ± 0.4 3.9 ± 0.3 3.4 ± 0.4 3.8 ± 0.2 3.3 ± 0.4 &lt; 0.0001 Hemoglobin (g/dL) 10.7 ± 1.3 11.0 ± 1.1 10.8 ± 1.2 10.1 ± 1.3 10.4 ± 1.5 0.0016 T-Cho (mg/dL) 152 ± 34 155 ± 35 146 ± 28 155 ± 34 142 ± 33 0.19 Uric acid (mg/dL) 7.1 ± 1.3 7.2 ± 1.7 7.4 ± 1.7 6.7 ± 2.3 6.8 ± 1.6 0.43 Ca (mg/dL) 8.8 ± 0.9 8.9 ± 0.9 8.5 ± 0.9 9.0 ± 0.8 8.7 ± 0.9 0.10 P (mg/dL) 5.2 ± 1.3 5.4 ± 1.3 4.7 ± 0.9 5.1 ± 1.5 4.9 ± 1.3 0.067 iPTH (pg/mL) 126 (45-215) 142 (52-231) 69 (23-130) 115 (48-266) 127 (25-210) 0.064 Glucose (mg/dL) 138 ± 59 144 ± 66 141 ± 64 123 ± 39 133 ± 53 0.35 CRP (mg/dL) 0.15 (0.06-0.39) 0.11 (0.06-0.28) 0.24 (0.07-0.85) 0.18 (0.06-0.33) 0.29 (0.03-1.13) 0.048 Ferritin (ng/mL) 110 (49-201) 116 (60-204) 144 (83-199) 86 (27-167) 99 (40-221) 0.25 TSAT (%) 26.1 ± 12.7 27.3 ± 11.2 33.1 ± 20.6 23.1 ± 11.8 21.6 ± 9.1 0.0041 ESA dose (IU/week) 4500 (4000-9000) 4500 (2250-4500) 4000 (2250-4500) 9000 (9000-9000) 9000 (8000-9000) &lt; 0.0001 ERI (IU/week/kg/g/dL) 8.7 (5.2-14.9)</s><s xml:id="_HHCpf2X">6.1 (3.7-8.6)</s><s xml:id="_cMeUGW2">6.5 (4.8-7.5)</s><s xml:id="_M24S3BV">16.8 (14.8-19.4)</s><s xml:id="_TKZW8HZ">15.2 (11.8-19.9)</s><s xml:id="_7BFkCDQ">&lt; 0.0001 GNRI 94.5 ± 6.9 98.8 ± 4.2 87.0 ± 3.8 96.1 ± 3.0 86.0 ± 5.0 &lt; 0.0001 Abbreviations: HD: Hemodialysis, BMI: Body mass index, BUN: Blood urea nitrogen, T-Cho: Total cholesterol, CRP: C-reactive protein, CVD: Cardiovascular disease, Dw: Dry weight, ESA: Erythropoiesis-stimulating agent, ERI: Erythropoiesis-stimulating agent resistance index, GNRI: Geriatric nutritional risk index, TSAT: Transferrin saturation G1: Higher GNRI and lower ERI, G2: Higher GNRI and higher ERI, G3: Lower GNRI and lower ERI, G4: Lower GNRI and higher ERI.</s><s xml:id="_uFntZpN"><ref type="url" target="https://doi.org/10.1371/journal.pone.0245625.t001">https://doi.org/10.1371/journal.pone.0245625.t001</ref></s></p><p xml:id="_GU8G8z4"><s xml:id="_gHjPZAt">creatinine (β = -0.174,</s><s xml:id="_PUFPcax">p = 0.020), TSAT (β = -0.326,</s><s xml:id="_s5FxebZ">p &lt;0.0001), and the GNRI (β = -0.349,</s><s xml:id="_e3dbHZZ">p &lt;0.0001).</s><s xml:id="_mM7jKQr">Multivariate regression analysis, following adjustment for all significant confounders in univariate analysis, revealed that the ERI was independently correlated with TSAT (β = -0.289,</s><s xml:id="_VDVrURX">p &lt;0.0001) and the GNRI (β = -0.271,</s><s xml:id="_eRYjXA6">p = 0.0005) (Table <ref type="table">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_evZMZ49">Associations of the GNRI and ERI with CVD mortality</head><p xml:id="_3MXRyY5"><s xml:id="_bSzDwxK">A total of 63 patients died during the follow-up period (4.6 [2.5-8.2]</s><s xml:id="_NTcrBDS">years), including 28 (44.4%)</s><s xml:id="_Gf5aQhz">due to CVD-specific causes (14 heart failures, 7 sudden cardiac deaths or fatal arrhythmias, 4 strokes, and 3 myocardial infarctions), and 35 due to non-CVD-specific causes (25 infections, 7 malignancies, and 3 others).</s></p><p xml:id="_frw5e3n"><s xml:id="_HkBGpPB">In the multivariate Cox proportional hazards analysis adjusted by age, history of cardiovascular disease, creatinine, and C-reactive protein (CRP), which were significant in the</s></p><p xml:id="_QqEhdMS"><s xml:id="_RFzUt3m">Table 2. Univariate and multivariate regression analysis of the associations between the erythropoiesis-stimulating agent resistance index and baseline variables.</s><s xml:id="_8KpDMtG">Univariate Multivariate Variables β p-value β p-value Age 0.254 0.0006 0.054 0.53 Creatinine -0.174 0.020 -0.069 0.38 TSAT -0.326 &lt; 0.0001 -0.289 &lt; 0.0001 GNRI -0.349 &lt; 0.0001 -0.271 0.0005 Abbreviations: TSAT: Transferrin saturation, GNRI: Geriatric nutritional risk index.</s><s xml:id="_Z46EbRH"><ref type="url" target="https://doi.org/10.1371/journal.pone.0245625.t002">https://doi.org/10.1371/journal.pone.0245625.t002</ref></s><s xml:id="_tXaNXCV">Table 3. Cox proportional hazards analysis of the erythropoiesis-stimulating agent resistance index and the geriatric nutritional risk index for mortality.</s><s xml:id="_qPXu9yr">Variables Non-adjusted Adjusted � HR (95%CI) p-value HR (95%CI) p-value Cardiovascular mortality GNRI (continuous) 0.87 (0.82-0.92) &lt; 0.0001 0.90 (0.84-0.96) 0.0020 ERI (continuous) 1.09 (1.05-1.13)</s><s xml:id="_QydY9Bf">&lt; 0.0001 1.07 (1.02-1.11)</s><s xml:id="_jHeyf8C">0.0050 Lower GNRI 4.52 (2.10-9.73)</s><s xml:id="_z4JSvzj">0.0001 3.10 (1.31-7.34)</s><s xml:id="_akZzz2S">0.0099 Higher ERI 8.19 (3.58-18.74)</s><s xml:id="_NKfxmJe">&lt; 0.0001 6.64 (2.60-16.93)</s><s xml:id="_pfwuXja">&lt; 0.0001 Cross-classified (vs.</s><s xml:id="_Z3pWqsu">G1) &lt; 0.0001 &lt; 0.0001 G2 6.77 (1.85-24.76)</s><s xml:id="_P7uctwX">0.0039 6.70 (1.60-28.16)</s><s xml:id="_QN6sqzv">0.0094 G3 8.62 (2.94-25.30)</s><s xml:id="_NcbJbVV">&lt; 0.0001 9.58 (2.83-32.45)</s><s xml:id="_AS8AJpx">0.0003 G4 13.75 (4.74-39.88)</s><s xml:id="_gTxneUU">&lt; 0.0001 12.63 (3.58-44.59)</s><s xml:id="_paTWzqn">&lt; 0.0001 All-cause mortality GNRI (continuous) 0.88 (0.85-0.91) &lt; 0.0001 0.92 (0.88-0.96) 0.00012 ERI (continuous) 1.08 (1.05-1.10)</s><s xml:id="_MGedwaV">&lt; 0.0001 1.06 (1.03-1.08)</s><s xml:id="_VT9Gq7d">0.00019 Lower GNRI 5.14 (3.09-8.56)</s><s xml:id="_HEqReMd">&lt; 0.0001 3.36 (1.92-5.87)</s><s xml:id="_8dgXHPK">&lt; 0.0001 Higher ERI 3.38 (2.01-5.70)</s><s xml:id="_Y9jnvdm">&lt; 0.0001 2.49 (1.42-4.37)</s><s xml:id="_q5S6wEP">0.0015 Cross-classified (vs.</s><s xml:id="_dV6ajYB">G1) &lt; 0.0001 &lt; 0.0001 G2 6.05 (2.85-12.86)</s><s xml:id="_TwA8SK7">&lt; 0.0001 4.33 (1.93-9.72)</s><s xml:id="_qCwbTzX">0.0004 G3 3.55 (1.70-7.44)</s><s xml:id="_a6hBCTD">0.0008 2.91 (1.34-6.32)</s><s xml:id="_CxNtEuR">0.0071 G4 9.18 (4.73-17.82)</s><s xml:id="_HkS2YXy">&lt; 0.0001 5.87 (2.81-12.24)</s><s xml:id="_F6vFWPy">&lt; 0.0001 Abbreviations: ERI: Erythropoiesis-stimulating agent resistance index, GNRI: Geriatric nutritional risk index.</s><s xml:id="_RfRxPHM">� Adjusted for age, history of cardiovascular disease, creatinine, and C-reactive protein, which were significant in the univariate analysis.</s><s xml:id="_4NqRq4T"><ref type="url" target="https://doi.org/10.1371/journal.pone.0245625.t003">https://doi.org/10.1371/journal.pone.0245625.t003</ref></s></p><p xml:id="_HdJ5pQM"><s xml:id="_TSRCTsD">univariate analysis, the GNRI and ERI were significant predictors for CVD mortality (HR, 0.87; 95%CI, 0.82-0.92,</s><s xml:id="_ds9SxFM">and HR, 1.09; 95%CI, 1.05-1.13,</s><s xml:id="_ZZ89Q4S">respectively) (Table <ref type="table">3</ref>).</s><s xml:id="_5KP5tJX">ROC analysis was performed to obtain the optimal cut-off values of the ERI for predicting the risk of CVD mortality.</s><s xml:id="_RnaYvBZ">The cut-off value of the ERI was 13.7 IU/week/kg/g/dL (AUC = 0.655, p = 0.025).</s><s xml:id="_RdBkvH8">First, patients were divided by the GNRI of 91.2 into low and high groups, in which the 7-year CVD survival rates were 60.1% and 91.6%, respectively (p &lt; 0.0001) (Fig <ref type="figure" target="#fig_0">1A</ref>).</s><s xml:id="_rw9TdmM">Second, patients were then divided by the ERI of 13.7 IU/week/kg/g/dL into low and high groups, in which the 7-year CVD survival rates were 91.8% and 65.2%, respectively (p &lt; 0.0001) (Fig <ref type="figure" target="#fig_0">1B</ref>).</s><s xml:id="_zG4vvZp">Third, the patients were divided by each cut-off point of the GNRI and ERI into G1, G2, G3, and G4 groups, in which the 7-year CVD survival rates were 96.1%, 70.3%, 77.3%, and 50.1% (Fig <ref type="figure" target="#fig_0">1C</ref>).</s><s xml:id="_UNpSpnY">Multivariate Cox proportional hazards analysis was performed after adjusting for age, history of CVD, creatinine, and CRP, which were significant in the univariate analysis.</s><s xml:id="_ATMqS9e">The adjusted HR (aHR) values for CVD mortality were 3.10 (95%CI, 1.31-7.34,</s><s xml:id="_KqBMs4b">p = 0.0099) for lower GNRI, and 6.64 (95%CI, 2.60-16.93,</s><s xml:id="_pPrUdCV">p &lt; 0.0001) for higher ERI.</s><s xml:id="_KdgerqC">Moreover, the aHR values were 6.70 (95%CI, 1.60-28.16,</s><s xml:id="_6mhRv2E">p = 0.0094) for G2 vs G1, 9.58 (95%CI, 2.83-32.45,</s><s xml:id="_xVqnb5D">p = 0.0003) for G3 vs G1, and 12.63 (95%CI, 3.58-44.59,</s><s xml:id="_jpArn29">p &lt; 0.0001) for G4 vs G1 (Table <ref type="table">3</ref>).</s><s xml:id="_FrgCRTs">Similar results were obtained for all-cause mortality (Table <ref type="table">3</ref>, Fig 1D <ref type="figure" target="#fig_0">-1F</ref>).</s></p><p xml:id="_PVaaVGe"><s xml:id="_9rnGtgB">With regards to the model discrimination, the C-index for CVD mortality was greater in the model adding the GNRI alone (0.708, p = 0.83), the ERI alone (0.747, p = 0.28), and both variables (0.753, p = 0.26) compared to the traditional risk model (0.708), but did not reach Cardiovascular mortality for lower GNRI vs. higher GNRI (a), lower ERI vs. higher ERI (b), and among the four groups divided by the GNRI and the ERI (c).</s><s xml:id="_6dHHd9Q">All-cause mortality for lower GNRI vs. higher GNRI (d), lower ERI vs. higher ERI (e), and among the four groups divided by the GNRI and the ERI (f).</s><s xml:id="_7BKRVQP">ERI: Erythropoiesis-stimulating agent resistance index, GNRI: Geriatric nutritional risk index.</s><s xml:id="_XVeQCqF">G1: Higher GNRI and lower ERI, G2: Higher GNRI and higher ERI, G3: Lower GNRI and lower ERI, G4: Lower GNRI and higher ERI.</s><s xml:id="_TdgdQqb"><ref type="url" target="https://doi.org/10.1371/journal.pone.0245625.g001">https://doi.org/10.1371/journal.pone.0245625.g001</ref></s><s xml:id="_xTbYCPE">statistical significance.</s><s xml:id="_EUFeyBq">However, The NRI and IDI values for CVD mortality improved by adding the GNRI alone (0.421 [p = 0.020] and 0.011 [p = 0.093], respectively), the ERI alone (0.662 [p = 0.00065] and 0.041 [p = 0.025], respectively), and both variables (0.671 [p = 0.00055] and 0.041 [p = 0.0097], respectively) to the traditional risk model (Table <ref type="table" target="#tab_3">4</ref>).</s><s xml:id="_DrAve4U">Similar results were obtained for all-cause mortality (Table <ref type="table" target="#tab_3">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KCt4XSt">Discussion</head><p xml:id="_eVpbABr"><s xml:id="_C2csMJD">The results of the present study showed that the ERI was negatively and independently associated with the GNRI, and could predict CVD and all-cause mortality in patients undergoing maintenance HD.</s><s xml:id="_EdmeX8C">Moreover, the combination of the ERI and the GNRI could not only stratify the risk, but also improve the predictability for mortality.</s><s xml:id="_a4AXZ2b">Therefore, both the ERI and the GNRI should be evaluated to more accurately predict CVD mortality in this population.</s></p><p xml:id="_46Rpc9e"><s xml:id="_GF4ndkA">The most common causes of ESA hyporesponsiveness are iron deficiency, either absolute or functional, inflammation, and malnutrition <ref type="bibr" target="#b8">[9]</ref>.</s><s xml:id="_4xqzYdF">Absolute iron deficiency may be due to external blood losses through the extracorporeal blood circuit or dialyzers, and/or exhaustion of iron stores due to an increase in erythropoiesis caused by ESA treatment.</s><s xml:id="_5YAqMFd">In this situation, iron administration to maintain adequate iron stores is required for reducing the ESA dose and for enhancing ESA efficacy.</s><s xml:id="_YDBSANZ">However, some clinical trials have shown that iron administration to ESRD patients is associated with increased risks of infection, CVD, hospitalization, and mortality <ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref>.</s><s xml:id="_pfPJyU9">Functional iron deficiency is a condition in which iron utilization is defective in the bone marrow due to chronic inflammation despite sufficient iron stores.</s><s xml:id="_pHYmBB5">Malnutrition is closely related to inflammation and atherosclerosis <ref type="bibr" target="#b24">[25]</ref>, and through common mediators such as IL-6 or TNF-α, it may play a relevant role in ESA hyporesponsiveness <ref type="bibr" target="#b25">[26]</ref>.</s></p><p xml:id="_KJVWnEP"><s xml:id="_pkGqEXs">On the other hand, PEW is a state of malnutrition, which is frequently complicated with chronic kidney disease, and is associated with an increased risk of mortality <ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref>.</s><s xml:id="_H9dQrNM">Some previous studies have reported that a loss of muscle mass and fat mass in the presence of inflammation leads to an increased risk of CVD mortality by promoting vascular endothelial damage <ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref>.</s><s xml:id="_4guxZUs">As an indicator of PEW, the GNRI, a simple and objective method for evaluating nutritional status, is well-known in HD patients.</s><s xml:id="_PV9pcaG">Bouillanne et al. firstly reported that the GNRI was a prognostic indicator of morbidity and mortality in elderly hospitalized patients at nutritional risk <ref type="bibr" target="#b32">[33]</ref>.</s><s xml:id="_gx3CkTx">Yamada et al. reported that the GNRI was the most reliable screening tool for predicting malnutrition compared with other simple nutritional screening tools in maintenance hemodialysis patients <ref type="bibr" target="#b12">[13]</ref>.</s><s xml:id="_KQhjU5Y">They also determined the cutoff value of 91.2 for GNRI with the use of MIS as the standard reference, in this population <ref type="bibr" target="#b12">[13]</ref>.</s><s xml:id="_m6eRFGJ">Thereafter, many studies showed that the GNRI is a useful tool for stratifying malnutritional risks <ref type="bibr" target="#b13">[14]</ref> and identifying nutrition-related risks of CVD events and all-cause or CVD mortality in HD patients <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b33">34]</ref>.</s><s xml:id="_ac47WzQ">A meta-analysis conducted by Xiong et al. also concluded that the GNRI is a significant indicator for predicting both all-cause and CVD mortality in patients undergoing HD <ref type="bibr" target="#b16">[17]</ref>.</s><s xml:id="_VrFQ2aB">Furthermore, we have recently reported that the ratio of extracellular fluid to intracellular fluid measured by bio-impedance analysis, a new marker of PEW, predicted not only allcause, but also CVD mortality in patients undergoing HD <ref type="bibr" target="#b34">[35]</ref>.</s><s xml:id="_mFvxreN">Moreover, we have also revealed that the combining the ratio of extracellular fluid to intracellular fluid with the GNRI could improve predictability for mortality <ref type="bibr" target="#b34">[35]</ref>.</s></p><p xml:id="_hNzsXXa"><s xml:id="_qwCNYk5">Several recent studies have reported the possible association between ESA hyporesponsiveness and PEW.</s><s xml:id="_z48BSht">Rattanasompattikul et al. have reported that the ERI was independently correlated with malnutritional-inflammation score, a comprehensive scoring system of nutrition in maintenance HD patients, and that the score was worse in the 4 th quartile of ERI compared to the 1 st quartile <ref type="bibr" target="#b9">[10]</ref>.</s><s xml:id="_Mj4RnKh">Furthermore, Gonza ´lez-Ortiz et al. recently reported that HD patients with PEW, which was classified by malnutritional-inflammation score, have increased risks for the poorer response to ESA therapy than those without PEW <ref type="bibr" target="#b10">[11]</ref>.</s><s xml:id="_3M6kbbk">In this study, the ERI was negatively, independently associated with GNRI, a marker of PEW; therefore, our findings supported that the ERI may be a plausible indicator of PEW.</s></p><p xml:id="_j9Uj4ha"><s xml:id="_zS6Z7G5">In this study, higher ERI and lower GNRI were independently associated with CVD and all-cause mortality, respectively.</s><s xml:id="_RPAcRZc">Many observational studies have shown that the GNRI predicts all-cause and CVD mortality <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref>.</s><s xml:id="_hhJuxcA">Although the associations between the ERI and allcause mortality and CVD events has been already reported <ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref>, the relationship between the ERI and CVD mortality remains unknown.</s><s xml:id="_z6g2M3c">Therefore, for the first time, we show that the ERI was a significant predictor for CVD mortality in HD patients.</s><s xml:id="_uegpEGF">In the present study, the proportion of patients with a history of previous CVD was relatively high, and the study follow-up period was relatively long; thus, it was possible to determine the association between the ERI and CVD mortality.</s><s xml:id="_XAgATMB">More interestingly, combining the ERI with the GNRI could stratify the risk of CVD mortality and improve the predictability.</s><s xml:id="_pdreZ7j">Therefore, both the ERI and the GNRI should be simultaneously evaluated in HD patients.</s></p><p xml:id="_fPHb4nU"><s xml:id="_NnAqHnU">There were several limitations to this study.</s><s xml:id="_JECccsH">First, the present study was a single-center retrospective study with a relatively small number of participants.</s><s xml:id="_kGhqr2e">Second, patients with renal anemia who were treated with epoetin beta or darbepoetin alfa, but not with epoetin beta pegol were included.</s><s xml:id="_YNYmDCd">Since darbepoetin alfa but not epoetin beta pegol can be converted to the ESA dose of epoetin beta, our results might not be applicable to all patients in whom renal anemia is treated with ESAs.</s><s xml:id="_Gmz72EB">Third, the use of only baseline ERI and GNRI for data analysis was not allowed to consider any changes of these indicators during the follow-up periods.</s><s xml:id="_qfQwTq4">In addition, the changes of dialysis dose, nutritional status, and iron status markers might help to clarify the potential causes of a linked change of ERI, therefore future study may be needed to reveal these associations.</s><s xml:id="_Z6Ch4Hk">Fourth, this study only included Japanese patients, and as such, our findings might not be representative of maintenance HD patients in other countries.</s><s xml:id="_XWJn6Da">Therefore, a further large-scale multicenter study may be needed to validate our results.</s></p><p xml:id="_Z5Ue5GA"><s xml:id="_PZAY2US">In conclusion, the ERI was independently associated with the GNRI and could predict CVD, as well as all-cause mortality in patients undergoing HD.</s><s xml:id="_k2YGwyd">Moreover, combining the ERI and the GNRI could not only stratify the risk of CVD and all-cause mortality, but could also improve the predictability for mortality.</s><s xml:id="_xvm8PUQ">Therefore, both the ERI and the GNRI should be evaluated to more accurately predict CVD and all-cause mortality in this population.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig 1 .</head><label>1</label><figDesc><div><p xml:id="_9pwDgKA"><s xml:id="_bxPd6dt">Fig 1. Kaplan-Meier survival curves for cardiovascular and all-cause mortality.Cardiovascular mortality for lower GNRI vs. higher GNRI (a), lower ERI vs. higher ERI (b), and among the four groups divided by the GNRI and the ERI (c).</s><s xml:id="_9TBtNY9">All-cause mortality for lower GNRI vs. higher GNRI (d), lower ERI vs. higher ERI (e), and among the four groups divided by the GNRI and the ERI (f).</s><s xml:id="_y55cwr7">ERI: Erythropoiesis-stimulating agent resistance index, GNRI: Geriatric nutritional risk index.</s><s xml:id="_Xccq9Y5">G1: Higher GNRI and lower ERI, G2: Higher GNRI and higher ERI, G3: Lower GNRI and lower ERI, G4: Lower GNRI and higher ERI.</s></p></div></figDesc><graphic coords="6,89.06,78.01,486.94,291.57" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 . Predictive accuracy of the erythropoiesis-stimulating agent resistance index and the geriatric nutritional risk index for mortality.</head><label>4</label><figDesc><div><p xml:id="_HRpT8fn"><s xml:id="_uaRmg3D">ERI: Erythropoiesis-stimulating agent resistance index, GNRI: Geriatric nutritional risk index.</s><s xml:id="_vXv4GJQ">� Traditional risk factors include age, history of cardiovascular disease, creatinine, and C-reactive protein.</s></p></div></figDesc><table><row><cell>Variables</cell><cell>C-index</cell><cell>p-value</cell><cell>NRI</cell><cell>p-value</cell><cell>IDI</cell><cell>p-value</cell></row><row><cell>Cardiovascular mortality</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Traditional risk factors �</cell><cell>0.704 (0.589-0.820)</cell><cell></cell><cell>Ref.</cell><cell></cell><cell>Ref.</cell><cell></cell></row><row><cell>+ GNRI</cell><cell>0.708 (0.589-0.827)</cell><cell>0.83</cell><cell>0.421</cell><cell>0.020</cell><cell>0.011</cell><cell>0.093</cell></row><row><cell>+ ERI</cell><cell>0.747 (0.650-0.844)</cell><cell>0.28</cell><cell>0.662</cell><cell>0.00065</cell><cell>0.041</cell><cell>0.025</cell></row><row><cell>+ GNRI and ERI</cell><cell>0.753 (0.659-0.846)</cell><cell>0.26</cell><cell>0.671</cell><cell>0.00055</cell><cell>0.041</cell><cell>0.0097</cell></row><row><cell>All-cause mortality</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Traditional risk factors �</cell><cell>0.722 (0.645-0.799)</cell><cell></cell><cell>Ref.</cell><cell></cell><cell>Ref.</cell><cell></cell></row><row><cell>+ GNRI</cell><cell>0.744 (0.667-0.820)</cell><cell>0.37</cell><cell>0.574</cell><cell>0.00012</cell><cell>0.051</cell><cell>0.0016</cell></row><row><cell>+ ERI</cell><cell>0.729 (0.653-0.805)</cell><cell>0.70</cell><cell>0.374</cell><cell>0.0084</cell><cell>0.021</cell><cell>0.043</cell></row><row><cell>+ GNRI and ERI</cell><cell>0.767 (0.693-0.841)</cell><cell>0.11</cell><cell>0.713</cell><cell>&lt;0.00001</cell><cell>0.072</cell><cell>0.0001</cell></row><row><cell cols="2">Abbreviations: https://doi.org/10.1371/journal.pone.0245625.t004</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_px4TvbU"><s xml:id="_hShCZTT">PLOS ONE | https://doi.org/10.1371/journal.pone.0245625January</s><s xml:id="_fCakyyZ">15, 2021</s></p></note>
		</body>
		<back>


			<div type="funding">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_WsyTaeh"><p xml:id="_pwfEhWR"><s xml:id="_65HScFv">The authors received no specific funding for this work.</s></p></div>
			</div>


			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_f9FADNk"><p xml:id="_BEDcTky"><s xml:id="_e8sU8Rw">All relevant data are within the paper and its Supporting Information files.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_hs6nW47">Supporting information</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_w8Gp2CZ">S1 Data. (XLSX)</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9p37edq">Author Contributions</head><p xml:id="_Bcka75x"><s xml:id="_52qGHcD">Conceptualization: Takahiro Yajima, Kumiko Yajima, Hiroshi Takahashi.</s></p><p xml:id="_nsHKRWg"><s xml:id="_8wXV3YB">Data curation: Takahiro Yajima, Hiroshi Takahashi.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_PneEumJ">Formal analysis: Takahiro Yajima.</head><p xml:id="_NNyZeY5"><s xml:id="_N2fjdAg">Investigation: Takahiro Yajima, Kumiko Yajima, Hiroshi Takahashi.</s></p><p xml:id="_Ye7XNWu"><s xml:id="_Yx7rcn2">Methodology: Takahiro Yajima, Kumiko Yajima.</s></p><p xml:id="_n8PPwa9"><s xml:id="_ECjNgqp">Project administration: Takahiro Yajima, Kumiko Yajima, Hiroshi Takahashi.</s></p><p xml:id="_wSD4vB7"><s xml:id="_EMZQmx9">Supervision: Hiroshi Takahashi.</s></p><p xml:id="_dXHVpVz"><s xml:id="_ZdB6MzA">Validation: Takahiro Yajima, Hiroshi Takahashi.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_nUmMsR8">Writing -original draft: Takahiro Yajima.</head><p xml:id="_RHhMb7s"><s xml:id="_BAjm2Yh">Writing -review &amp; editing: Takahiro Yajima.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_x3CfU5Y">Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Kilpatrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Critchlow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fishbane</surname></persName>
		</author>
		<idno type="DOI">10.2215/cjn.04601007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8HuxBDH">Clin. J. Am. Soc. Nephrol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="1077" to="1083" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kilpatrick R.D, Critchlow C.W, Fishbane S, et al. Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2008; 3:1077-1083.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_5chtKSK">Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease?</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Kausz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Solid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Collins</forename><forename type="middle">A J</forename></persName>
		</author>
		<author>
			<persName><forename type="first">St</forename><surname>Peter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename></persName>
		</author>
		<idno type="DOI">10.1053/j.ajkd.2004.08.042</idno>
		<idno type="PMID">15696453</idno>
		<ptr target="https://doi.org/10.1053/j.ajkd.2004.08.042" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_bydBrmJ">Am. J. Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="136" to="147" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kausz A.T, Solid C, Pereira B.J, Collins A.J, St Peter W. Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease? Am. J. Kidney Dis. 2005; 45:136- 147. https://doi.org/10.1053/j.ajkd.2004.08.042 PMID: 15696453</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_nG4JWJ4">Epoetin requirements predict mortality in hemodialysis patients</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Thamer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stefanik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kaufman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Cotter</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0272-6386(04)01086-8</idno>
		<idno type="PMID">15492953</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mSsJTua">Am. J. Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="866" to="876" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhang Y, Thamer M, Stefanik K, Kaufman J, Cotter D.J. Epoetin requirements predict mortality in hemo- dialysis patients. Am. J. Kidney Dis. 2004; 44:866-876. PMID: 15492953</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_hGHAx3b">Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kalantar-Zadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lee</forename><forename type="middle">G H</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename></persName>
		</author>
		<idno type="DOI">10.1053/j.ajkd.2008.12.040</idno>
		<idno type="PMID">19339087</idno>
		<ptr target="https://doi.org/10.1053/j.ajkd.2008.12.040" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_88SNqM8">Am. J. Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="823" to="834" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kalantar-Zadeh K, Lee G.H, Miller J.E, et al. Predictors of hyporesponsiveness to erythropoiesis-stimu- lating agents in hemodialysis patients. Am. J. Kidney Dis. 2009; 53:823-834. https://doi.org/10.1053/j. ajkd.2008.12.040 PMID: 19339087</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_skewXeN">Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Sibbel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Koro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Brunelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Cobitz</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12882-015-0138-x</idno>
		<ptr target="https://doi.org/10.1186/s12882-015-0138-xPMID:26283069" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_hxGVNTv">B.M.C. Nephrol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">144</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sibbel S.P, Koro C.E, Brunelli S.M, Cobitz A.R. Characterization of chronic and acute ESA hypore- sponse: a retrospective cohort study of hemodialysis patients. B.M.C. Nephrol. 2015; 16:144. https:// doi.org/10.1186/s12882-015-0138-x PMID: 26283069</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_pnU6Bt8">Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results From the RISCAVID study</title>
		<author>
			<persName><forename type="first">V</forename><surname>Panichi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rosati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bigazzi</surname></persName>
		</author>
		<idno type="DOI">10.1093/ndt/gfq802</idno>
		<ptr target="https://doi.org/10.1093/ndt/gfq802PMID:21325348" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_AksBawM">Nephrol. Dial. Transplant</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2641" to="2648" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Panichi V, Rosati A, Bigazzi R, et al. RISCAVID Study Group. Anaemia and resistance to erythropoie- sis-stimulating agents as prognostic factors in haemodialysis patients: results From the RISCAVID study. Nephrol. Dial. Transplant. 2011; 26:2641-2648. https://doi.org/10.1093/ndt/gfq802 PMID: 21325348</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_T4fEQYd">Erythropoietin resistance index and the allcause mortality of chronic hemodialysis patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Okazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Komatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kawaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tsuchiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nitta</surname></persName>
		</author>
		<idno type="DOI">10.1159/000358215</idno>
		<ptr target="https://doi.org/10.1159/000358215PMID:24603656" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_wjbCpbb">Blood Purif</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="106" to="112" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Okazaki M, Komatsu M, Kawaguchi H, Tsuchiya K, Nitta K. Erythropoietin resistance index and the all- cause mortality of chronic hemodialysis patients. Blood Purif. 2014; 37:106-112. https://doi.org/10. 1159/000358215 PMID: 24603656</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_7CFwESf">Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Eriguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Taniguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ninomiya</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40620-014-0121-9</idno>
		<ptr target="https://doi.org/10.1007/s40620-014-0121-9PMID:25080399" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_fxCXPN7">J. Nephrol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="217" to="225" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Eriguchi R, Taniguchi M, Ninomiya T, et al. Hyporesponsiveness to erythropoiesis-stimulating agent as a prognostic factor in Japanese hemodialysis patients: the Q-Cohort study. J. Nephrol. 2015; 28:217- 225. https://doi.org/10.1007/s40620-014-0121-9 PMID: 25080399</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_G7AfPTp">Erythropoiesis stimulatory agent-resistant anemia in dialysis patients: review of causes and management</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kanbay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Perazella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kasapoglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Koroglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Covic</surname></persName>
		</author>
		<idno type="DOI">10.1159/000245041</idno>
		<ptr target="https://doi.org/10.1159/000245041PMID:19816014" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_QQpA2rU">Blood Purif</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1" to="12" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kanbay M, Perazella M.A, Kasapoglu B, Koroglu M, Covic A. Erythropoiesis stimulatory agent-resistant anemia in dialysis patients: review of causes and management. Blood Purif. 2010; 29:1-12. https://doi. org/10.1159/000245041 PMID: 19816014</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_Mn7A3mF">Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rattanasompattikul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Z</forename><surname>Molnar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Zaritsky</surname></persName>
		</author>
		<idno type="DOI">10.1093/ndt/gfs368</idno>
		<ptr target="https://doi.org/10.1093/ndt/gfs368PMID:23045431" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_jMyPReC">Nephrol. Dial. Transplant</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1936" to="1945" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rattanasompattikul M, Molnar M.Z, Zaritsky J.J, et al. Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients. Nephrol. Dial. Transplant. 2013; 28:1936-1945. https://doi.org/10.1093/ndt/gfs368 PMID: 23045431</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_pusZD7y">Relationship between protein-energy wasting in adults with chronic hemodialysis and the response to treatment with erythropoietin</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gonza ´lez-Ortiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Correa-Rotter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Va ´zquez-Rangel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Vega-Vega</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Espinosa-Cuevas</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12882-019-1457-0</idno>
		<ptr target="https://doi.org/10.1186/s12882-019-1457-0PMID:31412807" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_CTjCeTA">B.M.C. Nephrol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page">316</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gonza ´lez-Ortiz A, Correa-Rotter R, Va ´zquez-Rangel A, Vega-Vega O, Espinosa-Cuevas A ´. Relation- ship between protein-energy wasting in adults with chronic hemodialysis and the response to treatment with erythropoietin. B.M.C. Nephrol. 2019; 20:316. https://doi.org/10.1186/s12882-019-1457-0 PMID: 31412807</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_kgRdr2b">Associations between the erythropoiesis-stimulating agent resistance index and the geriatric nutritional risk index of maintenance hemodialysis patients and increased mortality</title>
		<author>
			<persName><forename type="first">M</forename><surname>Okazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Komatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shiohira</surname></persName>
		</author>
		<idno type="DOI">10.1186/s41100-015-0002-2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4DRVpzt">Ren. Replace. Ther</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">7</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Okazaki M, Komatsu M, Shiohira S, et al. Associations between the erythropoiesis-stimulating agent resistance index and the geriatric nutritional risk index of maintenance hemodialysis patients and increased mortality. Ren. Replace. Ther. 2015; 1:7.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_KS7ZCB2">Simplified nutritional screening tools for patients on maintenance hemodialysis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Furuya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Takita</surname></persName>
		</author>
		<idno type="DOI">10.1093/ajcn/87.1.106</idno>
		<ptr target="https://doi.org/10.1093/ajcn/87.1.106PMID:18175743" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_munVBbp">Am. J. Clin. Nutr</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="106" to="113" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yamada K, Furuya R, Takita T, et al. Simplified nutritional screening tools for patients on maintenance hemodialysis. Am. J. Clin. Nutr. 2008; 87:106-113. https://doi.org/10.1093/ajcn/87.1.106 PMID: 18175743</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_dG29hCz">Comparison of nutritional risk scores for predicting mortality in Japanese chronic hemodialysis patients</title>
		<author>
			<persName><forename type="first">H</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Inoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shimizu</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.jrn.2016.12.005</idno>
		<idno type="PMID">28215493</idno>
		<ptr target="https://doi.org/10.1053/j.jrn.2016.12.005" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_yZdQSyd">J. Ren. Nutr</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="201" to="206" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Takahashi H, Inoue K, Shimizu K, et al. Comparison of nutritional risk scores for predicting mortality in Japanese chronic hemodialysis patients. J. Ren. Nutr. 2017; 27:201-206. https://doi.org/10.1053/j.jrn. 2016.12.005 PMID: 28215493</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_u6AA8H2">Geriatric nutritional risk index, a simplified nutritional screening index, is a significant predictor of mortality in chronic dialysis patients</title>
		<author>
			<persName><forename type="first">I</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ishimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kato</surname></persName>
		</author>
		<idno type="DOI">10.1093/ndt/gfq211</idno>
		<ptr target="https://doi.org/10.1093/ndt/gfq211PMID:20400447" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_4zxBNbE">Nephrol. Dial. Transplant</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="3361" to="3365" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kobayashi I, Ishimura E, Kato Y, et al. Geriatric nutritional risk index, a simplified nutritional screening index, is a significant predictor of mortality in chronic dialysis patients. Nephrol. Dial. Transplant. 2010; 25:3361-3365. https://doi.org/10.1093/ndt/gfq211 PMID: 20400447</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_tffrMKh">Geriatric nutritional risk index accurately predicts cardiovascular mortality in incident hemodialysis patients</title>
		<author>
			<persName><forename type="first">H</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ishii</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jjcc.2013.10.018</idno>
		<idno type="PMID">24365385</idno>
		<ptr target="https://doi.org/10.1016/j.jjcc.2013.10.018" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_AdkWcFz">J. Cardiol</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="32" to="36" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Takahashi H, Ito Y, Ishii H, et al. Geriatric nutritional risk index accurately predicts cardiovascular mor- tality in incident hemodialysis patients. J. Cardiol. 2014; 64:32-36. https://doi.org/10.1016/j.jjcc.2013. 10.018 PMID: 24365385</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_4kW7JDz">Association of geriatric nutritional risk index with mortality in hemodialysis patients: A meta-analysis of cohort studies</title>
		<author>
			<persName><forename type="first">J</forename><surname>Xiong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1159/000495999</idno>
		<ptr target="https://doi.org/10.1159/000495999PMID:30566933" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_5CwczW5">Kidney Blood Press. Res</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1878" to="1889" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Xiong J, Wang M, Zhang Y, et al. Association of geriatric nutritional risk index with mortality in hemodial- ysis patients: A meta-analysis of cohort studies. Kidney Blood Press. Res. 2018; 43:1878-1889. https:// doi.org/10.1159/000495999 PMID: 30566933</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_ucUetAs">The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">Y</forename><surname>Cremieux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Audenrode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lefebvre</surname></persName>
		</author>
		<idno type="DOI">10.1185/030079906x154024</idno>
		<ptr target="https://doi.org/10.1185/030079906X154024PMID:17257447" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_eNu9kCc">Curr. Med. Res. Opin</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="2329" to="2336" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cremieux P.Y, Van Audenrode M, Lefebvre P. The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease. Curr. Med. Res. Opin. 2006; 22:2329-2336. https://doi.org/10.1185/ 030079906X154024 PMID: 17257447</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_GXMxqTg">A meta-analysis of the relative doses of erythropoiesis-stimulating agents in patients undergoing dialysis</title>
		<author>
			<persName><forename type="first">X</forename><surname>Bonafont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Carter</surname></persName>
		</author>
		<idno type="DOI">10.1093/ndtplus/sfp097</idno>
		<ptr target="https://doi.org/10.1093/ndtplus/sfp097PMID:25949339" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_5GKabsA">N.D.T. Plus</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="347" to="353" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bonafont X, Bock A, Carter D, et al. A meta-analysis of the relative doses of erythropoiesis-stimulating agents in patients undergoing dialysis. N.D.T. Plus 2009; 2:347-353. https://doi.org/10.1093/ndtplus/ sfp097 PMID: 25949339</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_wVAQpbr">Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Delong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Delong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Clarke-Pearson</surname></persName>
		</author>
		<idno type="DOI">10.2307/2531595</idno>
		<idno type="PMID">3203132</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EugPhE8">Biometrics</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="837" to="845" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
	<note type="raw_reference">DeLong E.R, DeLong D.M, Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845. PMID: 3203132</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_cwWPR7w">Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Pencina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D'</forename><surname>Agostino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Sr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D'</forename><surname>Agostino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Vasan</surname></persName>
		</author>
		<idno type="DOI">10.1002/sim.2929</idno>
		<ptr target="https://doi.org/10.1002/sim.2929PMID:17569110" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_UTP4dfu">Stat. Med</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="157" to="172" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pencina M.J, D&apos;Agostino R.B. Sr, D&apos;Agostino R.B. Jr, Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med. 2008; 27:157-172. https://doi.org/10.1002/sim.2929 PMID: 17569110</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_E3qVVVP">Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Brookhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Freburger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ellis</forename><forename type="middle">A R</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Winkelmayer</forename><forename type="middle">W C</forename><surname>Kshirsagar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename></persName>
		</author>
		<idno type="DOI">10.1681/asn.2012121164</idno>
		<ptr target="https://doi.org/10.1681/ASN.2012121164PMID:23787911" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_4EFs5Hk">J. Am. Soc. Nephrol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1151" to="1158" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brookhart M.A, Freburger J.K, Ellis A.R, Wang L, Winkelmayer W.C, Kshirsagar A.V. Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J. Am. Soc. Nephrol. 2013; 24:1151-1158. https://doi.org/10.1681/ASN.2012121164 PMID: 23787911</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_cCzbgD9">Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kuragano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Matsumura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Matsuda</surname></persName>
		</author>
		<idno type="DOI">10.1038/ki.2014.114</idno>
		<ptr target="https://doi.org/10.1038/ki.2014.114PMID:24759150" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_RZWQqch">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="845" to="854" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kuragano T, Matsumura O, Matsuda A, et al. Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients. Kidney Int. 2014; 86:845- 854. https://doi.org/10.1038/ki.2014.114 PMID: 24759150</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_PVxr6ZA">Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Bailie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Larkina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Goodkin</forename><forename type="middle">D A</forename></persName>
		</author>
		<idno type="DOI">10.1038/ki.2014.275</idno>
		<ptr target="https://doi.org/10.1038/ki.2014.275PMID:25075769" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_RwmxDEM">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="162" to="168" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bailie G.R, Larkina M, Goodkin D.A, et al. Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality. Kidney Int. 2015; 87:162-168. https://doi.org/10.1038/ki.2014.275 PMID: 25075769</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_K4cUnBc">Inflammation in end-stage renal disease: sources, consequences, and therapy</title>
		<author>
			<persName><forename type="first">P</forename><surname>Stenvinkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Alvestrand</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1525-139x.2002.00083.x</idno>
		<idno type="PMID">12358637</idno>
		<ptr target="https://doi.org/10.1046/j.1525-139x.2002.00083.x" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_xJ8JmE3">Semin. Dial</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="329" to="337" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and ther- apy. Semin. Dial. 2002; 15:329-337. https://doi.org/10.1046/j.1525-139x.2002.00083.x PMID: 12358637</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_XGKR88z">Update on interleukin-6 and its role in chronic renal failure</title>
		<author>
			<persName><forename type="first">R</forename><surname>Pecoits-Filho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lindholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Axelsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Stenvinkel</surname></persName>
		</author>
		<idno type="DOI">10.1093/ndt/gfg111</idno>
		<ptr target="https://doi.org/10.1093/ndt/gfg111PMID:12748331" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_w6eCsh2">Nephrol. Dial. Transplant</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1042" to="1045" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pecoits-Filho R, Lindholm B, Axelsson J, Stenvinkel P. Update on interleukin-6 and its role in chronic renal failure. Nephrol. Dial. Transplant. 2003; 18:1042-1045. https://doi.org/10.1093/ndt/gfg111 PMID: 12748331</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_nBvCKkJ">A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease</title>
		<author>
			<persName><forename type="first">D</forename><surname>Fouque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kalantar-Zadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kopple</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.ki.5002585</idno>
		<ptr target="https://doi.org/10.1038/sj.ki.5002585PMID:18094682" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_gVhHsJQ">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="391" to="398" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for pro- tein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008; 73:391-398. https://doi.org/ 10.1038/sj.ki.5002585 PMID: 18094682</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_QkJDP9F">The impact of abdominal fat levels on all-cause mortality risk in patients undergoing hemodialysis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yasuda</surname></persName>
		</author>
		<idno type="DOI">10.3390/nu10040480</idno>
		<ptr target="https://doi.org/10.3390/nu10040480PMID:29649164" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_QVbXbTW">Nutrients</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">480</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yajima T, Yajima K, Takahashi H, Yasuda K. The impact of abdominal fat levels on all-cause mortality risk in patients undergoing hemodialysis. Nutrients 2018; 10:480. https://doi.org/10.3390/nu10040480 PMID: 29649164</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_dkPjxXj">The associations of fat tissue and muscle mass indices with all-cause mortality in patients undergoing hemodialysis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Arao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yasuda</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0211988</idno>
		<idno type="PMID">30759133</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0211988" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_6pdtfRG">PLOS ONE</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">211988</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yajima T, Arao M, Yajima K, Takahashi H, Yasuda K. The associations of fat tissue and muscle mass indices with all-cause mortality in patients undergoing hemodialysis. PLOS ONE 2019; 14:e0211988. https://doi.org/10.1371/journal.pone.0211988 PMID: 30759133</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_5eArMym">Inflammation enhances cardiovascular risk and mortality in hemodialysis patients</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zimmermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Herrlinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pruy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Metzger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wanner</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1523-1755.1999.00273.x</idno>
		<idno type="PMID">9987089</idno>
		<ptr target="https://doi.org/10.1046/j.1523-1755.1999.00273.x" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_9FPzeEY">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="648" to="658" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999; 55:648-658. https://doi.org/10.1046/j.1523- 1755.1999.00273.x PMID: 9987089</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_DApaAJs">Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Qureshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Alvestrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Divino-Filho</surname></persName>
		</author>
		<idno type="DOI">10.1681/asn.v13suppl_1s28</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HYs7uzP">J. Am. Soc. Nephrol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="28" to="36" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
	<note type="raw_reference">Qureshi A.R, Alvestrand A, Divino-Filho J.C, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J. Am. Soc. Nephrol. 2002; 13 (Suppl. 1):S28-36.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_fbgUGUH">Block comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kalantar-Zadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kopple</forename><forename type="middle">J D</forename><surname>Humphreys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Block</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<idno type="DOI">10.1093/ndt/gfh143</idno>
		<ptr target="https://doi.org/10.1093/ndt/gfh143PMID:15069177" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_VvsmXyT">Nephrol. Dial. Transplant</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1507" to="1519" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kalantar-Zadeh K, Kopple J.D, Humphreys M.H, Block G. Block comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol. Dial. Transplant. 2004; 19:1507-1519. https://doi.org/10.1093/ndt/gfh143 PMID: 15069177</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_RnG6Mhc">Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients</title>
		<author>
			<persName><forename type="first">O</forename><surname>Bouillanne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Morineau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dupont</surname></persName>
		</author>
		<idno type="DOI">10.1093/ajcn/82.4.777</idno>
		<ptr target="https://doi.org/10.1093/ajcn/82.4.777PMID:16210706" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_YDK6KV4">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="777" to="783" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bouillanne O, Morineau G, Dupont C, et al. Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr 2005; 82:777-783. https://doi.org/10.1093/ajcn/82.4.777 PMID: 16210706</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_zcBHnJ4">Impact of Annual Change in Geriatric Nutritional Risk Index on Mortality in Patients Undergoing Hemodialysis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takahashi</surname></persName>
		</author>
		<idno type="DOI">10.3390/nu12113333</idno>
		<ptr target="https://doi.org/10.3390/nu12113333PMID:33138201" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_XYRaUAk">Nutrients</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">3333</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yajima T, Yajima K, Takahashi H. Impact of Annual Change in Geriatric Nutritional Risk Index on Mor- tality in Patients Undergoing Hemodialysis. Nutrients. 2020; 12:3333. https://doi.org/10.3390/ nu12113333 PMID: 33138201</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_zMqj7jN">Combined predictive value of extracellular fluid/intracellular fluid ratio and the geriatric nutritional risk index for mortality in patients undergoing hemodialysis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yasuda</surname></persName>
		</author>
		<idno type="DOI">10.3390/nu11112659</idno>
		<ptr target="https://doi.org/10.3390/nu11112659PMID:31690024" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_BmFTZnj">Nutrients</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">2659</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yajima T, Yajima K, Takahashi H, Yasuda K. Combined predictive value of extracellular fluid/intracellu- lar fluid ratio and the geriatric nutritional risk index for mortality in patients undergoing hemodialysis. Nutrients 2019; 11:2659. https://doi.org/10.3390/nu11112659 PMID: 31690024</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
